http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-944208-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate | 1994-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1698b2ec3a6fb7b7968bdab8379f6495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c018fe2b3b721df049e6783745439974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d17c54eef5edde5309c3e52971ba267 |
| publicationDate | 1995-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NO-944208-L |
| titleOfInvention | Novel quinazolines as inhibitors of HIV reverse transcriptase |
| abstract | Compounds with a quinazolin-2-one nucleus having a substituted alkynyl or substituted alkenyl at the 4-position are described. These compounds are useful in inhibiting HIV reverse transcriptase (including its resistant variants), preventing or treating HIV infection and treating AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical preparations, or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods for treating AIDS and methods for preventing or treating HIV infection are also described. |
| priorityDate | 1992-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360260 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID344381 |
Total number of triples: 18.